Scientific Publications by FDA Staff
Nanomedicine 2013 Jul;9(5):594-9
Continuing to strengthen FDA's science approach to emerging technologies.
Anatol R, Bauer S, Epstein S, Filice R, Lauritsen K, Lee MH, Mansfield E, McMurry-Heath M, Milone J, Pena C, Pollack S, Zineh I
Emerging technologies result when advances and innovation in technology lead to discoveries. Often emerging technologies stimulate novel research in medical product development that contribute to new approaches to manufacturing and can improve the quality of products. By supporting investments in agency coordination, staff training and professional development, regulatory science research, stakeholder engagement, and enhancing opportunities for expert input, the U.S. Food and Drug Administration plays a critical role in translating innovations into novel safe and effective medical products that improve the public health.
|Category: Journal Article, Editorial|
|PubMed ID: #23692697||DOI: 10.1016/j.nano.2013.04.005|
|Includes FDA Authors from Scientific Area(s): Women's Health Biologics Medical Devices Drugs|
|Entry Created: 2013-05-23||Entry Last Modified: 2013-07-27|